Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
New research shows potentially deadly UV damage can appear decades earlier than you think.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?